DIA has awarded 15 scholarships to nationally recognized patient organizations that will cover registration fees and travel costs associated with attending the DIA 2011 Annual Meeting, June 19-21 in Chicago, IL.
With the launch of comparative effectiveness research (CER) and the Patient-Centered Research Outcomes Institute (PCORI), the importance of having advocates engaged in drug development is critical. The inaugural DIA Patient Advocacy Fellowship Program provides a chance for medical industry professionals to gather for a half-day of sessions designed to educate attendees on changes in federal health care policy and how policy may affect drug discovery and approval and patient access to new treatments. The program also provides information about how patient groups can get involved in this process to advocate on behalf of their members.
Fellowship recipients include:
- Alagille Syndrome Alliance
- American Kidney Fund
- Asthma and Allergy Foundation of America
- Autoimmune Diseases Association
- Hepatitis C Caring Ambassadors Program
- International Pemphigus & Pemphigoid Foundation
- Myasthenia Gravis Foundation
- National Alopecia Areata Foundation
- National Ataxia Foundation
- Pancreatic Cancer Action Network
- Parkinson's Disease Foundation
- Spinal Muscular Atrophy Foundation
- Susan G. Komen for the Cure
- Uniting Against Lung Cancer
- Women's Heart Foundation
For complete details regarding the DIA 2011 Annual Meeting visit www.diahome.org/registerdia2011.
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.